Factor H-IgG Chimeric Proteins as a Therapeutic Approach against the Gram-Positive Bacterial Pathogen Streptococcus pyogenes.
Factor H-IgG Chimeric Proteins as a Therapeutic Approach against the Gram-Positive Bacterial Pathogen Streptococcus pyogenes.
复制标题
DOI:
10.4049/jimmunol.1700426
复制
发表时间:
2017-12-01
期刊:
影响因子:
--
通讯作者:
Ermert D
中科院分区:
文献类型:
--
作者:
Blom AM;Magda M;Kohl L;Shaughnessy J;Lambris JD;Ram S;Ermert D
Bacteria can cause life-threatening infections, such as pneumonia, meningitis or sepsis. Antibiotic therapy is a mainstay of treatment, although antimicrobial resistance has drastically increased over the years. Unfortunately, safe and effective vaccines against most pathogens have not yet been approved, thus developing alternative treatments is important. We analyzed the efficiency of FH6-7/Fc, a novel antibacterial immunotherapeutic protein against the gram-positive bacterium Streptococcus pyogenes. This protein is composed of two domains of complement inhibitor human factor H (FH complement control protein modules 6 and 7) that bind to S. pyogenes, linked to the Fc region of IgG (FH6-7/Fc). FH6-7/Fc has previously been shown to enhance complement-dependent killing of and facilitate bacterial clearance in animal models of the gram-negative pathogens, Haemophilus influenzae and Neisseria meningitidis. We hypothesized that activation of complement by FH6-7/Fc on the surface of bacteria gram-positive bacteria such as S. pyogenes will enable professional phagocytes to eliminate the pathogen. We found that FH6-7/Fc alleviated S. pyogenes induced sepsis in a transgenic mouse model expressing human FH (S. pyogenes bind FH in a human-specific manner). Furthermore, FH6-7/Fc, which binds to Protein H and select M proteins, displaced FH from the bacterial surface, enhanced alternative pathway activation and reduced bacterial blood burden by opsonophagocytosis in a C3-dependent manner in an ex vivo human whole-blood model. In conclusion, FH-Fc chimeric proteins could serve as adjunctive treatments against multidrug-resistant bacterial infections.
登录
查看更多内容
影响因子:
4.8
作者:
Berge, A;Kihlberg, BM;Bjorck, L
通讯作者:
Bjorck, L
DOI:
10.1084/jem.148.4.1044
发表时间:
1978-10-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Fujita T;Gigli I;Nussenzweig V
通讯作者:
Nussenzweig V
DOI:
10.4049/jimmunol.0804031
发表时间:
2009-06-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Ferreira VP;Herbert AP;Cortés C;McKee KA;Blaum BS;Esswein ST;Uhrín D;Barlow PN;Pangburn MK;Kavanagh D
通讯作者:
Kavanagh D
影响因子:
3.6
作者:
Carlsson, F;Sandin, C;Lindahl, G
通讯作者:
Lindahl, G
影响因子:
6.7
作者:
Gustafsson MC;Lannergård J;Nilsson OR;Kristensen BM;Olsen JE;Harris CL;Ufret-Vincenty RL;Stålhammar-Carlemalm M;Lindahl G
通讯作者:
Lindahl G